Call for Papers

Advancing brain and spinal tumor research through rigorous peer-reviewed publication.

JBSC welcomes submissions across neuro-oncology disciplines including: glioblastoma, astrocytoma, oligodendroglioma, meningioma, ependymoma, spinal cord tumors, brain metastases, skull base tumors, molecular neuro-oncology, immunotherapy, targeted therapy, radiosurgery, surgical techniques, neuroimaging, quality of life, and survivorship.

• Expert Peer Review: Evaluation by active neuro-oncology specialists ensures quality
• Rapid Publication: Efficient editorial processes minimize time to publication
• DOI Assignment: Unique identifiers facilitate citation tracking
• Permanent Archiving: Long-term accessibility of CNS cancer research

JBSC particularly encourages manuscripts bridging laboratory discoveries with clinical applications. Research spanning preclinical models, biomarker development, and clinical trials advancing understanding of brain and spinal cancer treatment is highly valued.

We welcome manuscripts integrating neurosurgery, medical oncology, radiation oncology, neuropathology, and rehabilitation perspectives. Cross-disciplinary approaches strengthening patient care are especially encouraged.

JBSC prioritizes efficient processing while maintaining rigorous standards. Most manuscripts receive initial decisions within 3-4 weeks. Accepted articles publish online within 2-3 weeks of final acceptance.

JBSC welcomes contributions from neuro-oncologists worldwide. Authors from low and middle-income countries receive fee waiver consideration, ensuring global participation in advancing CNS cancer research.

Advanced neuroimaging studies characterizing tumor biology, treatment response, and surgical planning are particularly encouraged. Research leveraging AI and machine learning for CNS tumor diagnosis represents an emerging priority area.

Novel surgical techniques, intraoperative imaging applications, and functional preservation strategies are highly valued. Manuscripts demonstrating improved patient outcomes through technical innovation receive careful consideration.

Research advancing immunotherapy approaches for CNS tumors represents a key focus area. Studies on targeted molecular agents, combination strategies, and biomarker development are especially welcomed.

Studies addressing neurocognitive outcomes, functional recovery, and survivorship issues are encouraged. Patient-reported outcomes and caregiver perspectives strengthen the clinical relevance of published research.

Authors uncertain about manuscript suitability may submit pre-submission inquiries to [email protected]. Include brief description and key findings. Editorial guidance provided within 3-5 business days.

Case series and studies on rare CNS tumors are encouraged. Aggregating knowledge on uncommon entities benefits clinical practice worldwide. Collaborative multi-center studies on rare tumors are especially valuable.

JBSC encourages data deposition in appropriate repositories. Neuroimaging datasets, genomic data, and clinical registries enhance research reproducibility and enable secondary analyses advancing the field.

We welcome proposals for thematic special issues addressing emerging CNS cancer topics. Special issues provide focused platforms for comprehensive coverage. Contact editorial office to discuss potential themes.

Research on neurological rehabilitation following CNS tumor treatment addresses critical patient needs. Studies on functional recovery, cognitive rehabilitation, and return to function are encouraged.

Novel approaches to maximizing extent of resection while preserving function represent key surgical priorities. Awake craniotomy, intraoperative mapping, and fluorescence-guided surgery are active research areas.

Integration of molecular markers into diagnosis and prognosis represents evolving practice. Research advancing understanding of CNS tumor biology and classification is highly valued by our readership.

Stereotactic radiosurgery, proton therapy, and novel radiation approaches for CNS tumors are priority topics. Research on minimizing radiation toxicity while maximizing tumor control benefits the field.